HIV-positive women have higher prevalence of comorbidities and anticholinergic burden: assessment of the HIV-positive population from Menorca (Balearic Islands)

References

• Abrass, C. K., Appelbaum, J. S., & Boyd, C. M. (2017). The HIV and aging consensus project: Recommended treatment strategies for clinicians managing older patients with HIV. The HIV and aging consensus project. American Academy of HIV Medicine, 1–76. https://aahivm.org/wp-content/uploads/2017/02/Aging-report-working-document-FINAL-12.1.pdf
   Google Scholar
• Akbari, M., Fararouei, M., Haghdoost, A. A., Gouya, M. M., & Kazerooni, P. A. (2019). Survival and associated factors among people living with HIV/AIDS: A 30-year national survey in Iran. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 24, 5. https://doi.org/10.4103/jrms.JRMS_630_18
   PubMed Web of Science ®Google Scholar
• Amin, A. (2015). Addressing gender inequalities to improve the sexual and reproductive health and wellbeing of women living with HIV. Journal of The international Aids Society, 18(Suppl 5), 20302. https://doi.org/10.7448/IAS.18.6.20302
   PubMed Web of Science ®Google Scholar
• Bandelow, B., & Michaelis, S. (2015). Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience, 17(3), 327–335. https://doi.org/10.31887/DCNS.2015.17.3/bbandelow
   PubMed Web of Science ®Google Scholar
• Bastida, C., Grau, A., Márquez, M., Tuset, M., De Lazzari, E., Martínez, E., & Gatell, J. M. (2017). Polifarmacia e interacciones farmacológicas potenciales en una población envejecida con infección por el VIH [Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 41(5), 618–624. https://doi.org/10.7399/fh.10778
   PubMedGoogle Scholar
• Byrne, C. J., Walsh, C., Cahir, C., & Bennett, K. (2019). Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: A cohort study. BMC Geriatrics, 19(1), 121. https://doi.org/10.1186/s12877-019-1138-7
   PubMedGoogle Scholar
• Casajús-Navasal, A., Marín-Gorricho, R., Gallardo-Anciano, J., Nebot-Villacampa, M. J., Zafra-Morales, R., & González-Pérez, Y. (2018). Prevalencia de prescripción de fármacos anticolinérgicos en pacientes mayores con VIH [Prevalence of the consumption of anticholinergic drugs in HIV patients]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 42(1), 1–4. https://doi.org/10.7399/fh.10842
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). (2014). Revised surveillance case definition for HIV infection-United States. MMWR Recommendations and Reports, 63, 1–10. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm
   Web of Science ®Google Scholar
• Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. The Lancet: Infectious Diseases, 13(11), 976–986. https://doi.org/10.1016/S1473-3099(13)70269-X
   PubMed Web of Science ®Google Scholar
• Darlington, C. K., & Hutson, S. P. (2017). Understanding HIV-related stigma among women in the southern United States: A literature review. AIDS and Behavior, 21(1), 12–26. https://doi.org/10.1007/s10461-016-1504-9
   PubMed Web of Science ®Google Scholar
• Engler, K., Lessard, D., & Lebouché, B. (2017). A review of HIV-specific patient-reported outcome measures. The Patient, 10(2), 187–202. https://doi.org/10.1007/s40271-016-0195-7
   PubMedGoogle Scholar
• Gameiro, J., Jorge, S., & Lopes, J. A. (2018). HIV and renal disease: A contemporary review. International Journal of STD & AIDS, 29(7), 714–719. https://doi.org/10.1177/0956462417750710
   PubMed Web of Science ®Google Scholar
• GeSIDA (grupo de estudio del SIDA-SEIMC). Desprescripción farmacológica de la terapia no antiretroviral en pacientes con infección por VIH (update October 2018). Coord: JR Blanco, Ramón Morillo.
   Google Scholar
• Ghosn, J., Taiwo, B., Seedat, S., Autran, B., & Katlama, C. (2018). HIV. Lancet (London, England), 392(10148), 685–697. https://doi.org/10.1016/S0140-6736(18)31311-4
   PubMed Web of Science ®Google Scholar
• Greene, M., Steinman, M. A., McNicholl, I. R., & Valcour, V. (2014). Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. Journal of the American Geriatrics Society, 62(3), 447–453. https://doi.org/10.1111/jgs.12695
   PubMed Web of Science ®Google Scholar
• Hemelaar, J. (2019). HIV in Europe: A long road still lies ahead. The Lancet Infectious Diseases, 19(2), 1. https://doi.org/10.1016/S1473-3099(18)30647-9
   PubMedGoogle Scholar
• Hilmer, S. N. (2018). Calculating and using the drug burden index score in research and practice. Expert Review of Clinical Pharmacology, 11(11), 1053–1055. https://doi.org/10.1080/17512433.2018.1528145
   PubMed Web of Science ®Google Scholar
• Hilmer, S. N., Mager, D. E., Simonsick, E. M., Cao, Y., Ling, S. M., Windham, B. G., Harris, T. B., Hanlon, J. T., Rubin, S. M., Shorr, R. I., Bauer, D. C., & Abernethy, D. R. (2007). A drug burden index to define the functional burden of medications in older people. Archives of Internal Medicine, 167(8), 781–787. https://doi.org/10.1001/archinte.167.8.781
   PubMedGoogle Scholar
• Hughes, S., Hughes, A., Brothers, C., Spreen, W., Thorborn, D., & CNA106030 Study Team (2008). PREDICT-1 (CNA106030): The first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharmaceutical Statistics, 7(2), 121–129. https://doi.org/10.1002/pst.286
   PubMed Web of Science ®Google Scholar
• Ibarra-Barrueta, O., Mora-Atorrasagasti, O., Legarreta, M. J., Illaro-Uranga, A., & Morillo-Verdugo, R. (2019). Estudio piloto para desarrollar y validar un cuestionario basado en el índice de síntomas de VIH [Pilot study to develop and validate a questionnaire based on HIV symptoms index]. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 43(3), 87–93. https://doi.org/10.7399/fh.11127
   PubMedGoogle Scholar
• Ivanova, E. L., Hart, T. A., Wagner, A. C., Aljassem, K., & Loutfy, M. R. (2012). Correlates of anxiety in women living with HIV of reproductive age. AIDS and Behavior, 16(8), 2181–2191. https://doi.org/10.1007/s10461-011-0133-6
   PubMed Web of Science ®Google Scholar
• Ji, Y., & Lu, H. (2017). Malignancies in HIV-infected and AIDS patients. Advances in Experimental Medicine and Biology, 1018, 167–179. https://doi.org/10.1007/978-981-10-5765-6_10
   PubMed Web of Science ®Google Scholar
• Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., Weissman, S., Neidig, J., Marcus, C., Chesney, M., Cohn, S. E., Wu, A. W., & Adult AIDS Clinical Trials Unit Outcomes Committee. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54(Suppl 1), S77–S90. https://doi.org/10.1016/s0895-4356(01)00449-8
   PubMed Web of Science ®Google Scholar
• Kjær, A., Rasmussen, T. A., Hjollund, N. H., Rodkjaer, L. O., & Storgaard, M. (2018). Patient-reported outcomes in daily clinical practise in HIV outpatient care. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 69, 108–114. https://doi.org/10.1016/j.ijid.2018.02.015
   PubMed Web of Science ®Google Scholar
• Kouladjian, L., Gnjidic, D., Chen, T. F., & Hilmer, S. N. (2016). Development, validation and evaluation of an electronic pharmacological tool: The Drug Burden Index Calculator©. Research in Social & Administrative Pharmacy: RSAP, 12(6), 865–875. https://doi.org/10.1016/j.sapharm.2015.11.002
   PubMed Web of Science ®Google Scholar
• Lucas, S., & Nelson, A. M. (2015). HIV and the spectrum of human disease. The Journal of Pathology, 235(2), 229–241. https://doi.org/10.1002/path.4449
   PubMed Web of Science ®Google Scholar
• Marrone, G., Mellgren, Å, Eriksson, L. E., & Svedhem, V. (2016). High concordance between self-reported adherence, treatment outcome and satisfaction with care using a nine-item health questionnaire in InfCareHIV. PLoS One, 11(6), Article 0156916. https://doi.org/10.1371/journal.pone.0156916
   Web of Science ®Google Scholar
• Martin-Iguacel, R., Llibre, J. M., & Friis-Moller, N. (2015). Risk of cardiovascular disease in an aging HIV population: Where are we now? Current HIV/AIDS Reports, 12(4), 375–387. https://doi.org/10.1007/s11904-015-0284-6
   PubMed Web of Science ®Google Scholar
• Mazzitelli, M., Milinkovic, A., Pereira, B., Palmer, J., Tong, T., Asboe, D., & Boffito, M. (2019). Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV. AIDS (London, England), 33(15), 2439–2441. https://doi.org/10.1097/QAD.0000000000002403
   PubMed Web of Science ®Google Scholar
• Memòria VIH/SIDA de les Illes Balears. (2018). Consellera de Salut i Consum. Direcció General de Salut Pública i Participació. Govern de les Illes Balears.
   Google Scholar
• Miralles, C., Mardarescu, M., & Sherr, L. (2013). What do we know about the situation of women living with HIV in Europe? Antiviral Therapy, 18(Suppl 2), 11–17. https://doi.org/10.3851/IMP2646
   PubMed Web of Science ®Google Scholar
• Miralles, P., Navarro, J. T., Berenguer, J., Gómez Codina, J., Kwon, M., Serrano, D., Díez-Martín, J. L., Villà, S., Rubio, R., Menárguez, J., & Ribera Santasusana, J. M. (2018). Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana [GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus]. Medicina Clinica, 151(1), 39.e1–39.e17. https://doi.org/10.1016/j.medcli.2017.11.037
   PubMedGoogle Scholar
• Mofenson, L. M., Brady, M. T., Danner, S. P., Dominguez, K. L., Hazra, R., Handelsman, E., Havens, P., Nesheim, S., Read, J. S., Serchuck, L., Van Dyke, R., & Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, & American Academy of Pediatrics. (2009). Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 58(RR-11), 1–166.
   PubMedGoogle Scholar
• Moore, H. N., Mao, L., & Oramasionwu, C. U. (2015). Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH. AIDS Care, 27(12), 1443–1448. https://doi.org/10.1080/09540121.2015.1109583
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo, R., Blanco Ramos, J. R., Abdel-Kader Martín, L., & Álvarez de Sotomayor, M. (2018). The challenge of aging and pharmacotherapeutic complexity in the HIV+ patient. Farmacia Hospitalaria, 42(3), 120–127. https://doi.org/10.7399/fh.10931
   PubMed Web of Science ®Google Scholar
• Negredo, E., Domingo, P., Gutiérrez, F., Galindo, M. J., Knobel, H., Lozano, F., Martínez, E., Masiá, M., Polo, R., & Estrada, V. (2018). Executive summary of the consensus document on osteoporosis in HIV-infected individuals. Enfermedades infecciosas y microbiologia clinica, 36(5), 312–314. https://doi.org/10.1016/j.eimc.2017.03.010
   Web of Science ®Google Scholar
• Ngocho, J. S., Watt, M. H., Minja, L., Knettel, B. A., Mmbaga, B. T., Williams, P. P., & Sorsdahl, K. (2019). Depression and anxiety among pregnant women living with HIV in Kilimanjaro region, Tanzania. PLoS One, 14(10), Article 0224515. https://doi.org/10.1371/journal.pone.0224515
   Web of Science ®Google Scholar
• Nosrat, S., Whitworth, J. W., & Ciccolo, J. T. (2017). Exercise and mental health of people living with HIV: A systematic review. Chronic Illness, 13(4), 299–319. https://doi.org/10.1177/1742395317694224
   PubMed Web of Science ®Google Scholar
• O’Connell, J., Burke, É, Mulryan, N., O'Dwyer, C., Donegan, C., McCallion, P., McCarron, M., Henman, M. C., & O’Dwyer, M. (2018). Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study. British Journal of Clinical Pharmacology, 84(3), 553–567. https://doi.org/10.1111/bcp.13479
   PubMed Web of Science ®Google Scholar
• Obel, N., Omland, L. H., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Sørensen, H. T., & Gerstoft, J. (2011). Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: A population-based nationwide cohort study. PLoS One, 6(7), Article 22698. https://doi.org/10.1371/journal.pone.0022698
   Web of Science ®Google Scholar
• Parker, G., & Brotchie, H. (2010). Gender differences in depression. International Review of Psychiatry (Abingdon, England), 22(5), 429–436. https://doi.org/10.3109/09540261.2010.492391
   PubMed Web of Science ®Google Scholar
• Qin, S., Tan, Y., Lu, B., Cheng, Y., & Nong, Y. (2019). Survey and analysis for impact factors of psychological distress in HIV-infected pregnant women who continue pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 32(19), 3160–3167. https://doi.org/10.1080/14767058.2018.1459550
   PubMed Web of Science ®Google Scholar
• Rees, S., Silove, D., Chey, T., Ivancic, L., Steel, Z., Creamer, M., Teesson, M., Bryant, R., McFarlane, A. C., Mills, K. L., Slade, T., Carragher, N., O'Donnell, M., & Forbes, D. (2011). Lifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA, 306(5), 513–521. https://doi.org/10.1001/jama.2011.1098
   PubMed Web of Science ®Google Scholar
• Ryom, L., Boesecke, C., Bracchi, M., Ambrosioni, J., Pozniak, A., Arribas, J., Behrens, G., Mallon, P., Puoti, M., Rauch, A., Miro, J. M., Kirk, O., Marzolini, C., Lundgren, J. D., Battegay, M., & Governing Board, E. A. C. S. (2018). Highlights of the 2017 European AIDS clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0. HIV Medicine, 19(5), 309–315. https://doi.org/10.1111/hiv.12600
   PubMed Web of Science ®Google Scholar
• Scully, E. P. (2018). Sex differences in HIV infection. Current HIV/AIDS Reports, 15(2), 136–146. https://doi.org/10.1007/s11904-018-0383-2
   PubMed Web of Science ®Google Scholar
• Simpson, K. N., Hanson, K. A., Harding, G., Haider, S., Tawadrous, M., Khachatryan, A., Pashos, C. L., & Wu, A. W. (2013). Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: A 10-year review. Health and Quality of Life Outcomes, 11(1), 164. https://doi.org/10.1186/1477-7525-11-164
   PubMedGoogle Scholar
• Smit, M., Brinkman, K., Geerlings, S., Smit, C., Thyagarajan, K., Sighem, A. v., de Wolf, F., & Hallett, T. B., & ATHENA Observational Cohort. (2015). Future challenges for clinical care of an ageing population infected with HIV: A modelling study. The Lancet. Infectious Diseases, 15(7), 810–818. https://doi.org/10.1016/S1473-3099(15)00056-0
   PubMed Web of Science ®Google Scholar
• Sukasem, C., Chamnanphon, M., Koomdee, N., Santon, S., Jantararoungtong, T., Prommas, S., Puangpetch, A., & Manosuthi, W. (2014). Pharmacogenetics and clinical biomarkers for subtherapeutic plasma efavirenz concentration in HIV-1 infected Thai adults. Drug Metabolism and Pharmacokinetics, 29(4), 289–295. https://doi.org/10.2133/dmpk.dmpk-13-rg-077
   PubMed Web of Science ®Google Scholar
• Sullivan, P. S., Jones, J. S., & Baral, S. D. (2014). The global north: HIV epidemiology in high-income countries. Current Opinion in HIV and AIDS, 9(2), 199–205. https://doi.org/10.1097/COH.0000000000000039
   PubMed Web of Science ®Google Scholar
• Unidad de Vigilancia de VIH y Comportamientos de Riesgo. Vigilancia Epidemiológica del VIH y sida en España. (2018). Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Plan Nacional sobre el Sida – D.G. de Salud Pública, Calidad e Innovación/Centro Nacional de Epidemiología – ISCIII. Madrid, Spain. 2019. https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/doc/Informe_VIH_SIDA_2019_21112019.pdf
   Google Scholar
• Wing, E. J. (2016). HIV and aging. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 53, 61–68. https://doi.org/10.1016/j.ijid.2016.10.004
   PubMed Web of Science ®Google Scholar
• Yousuf, A., Musa, R., Isa, M., & Arifin, S. (2020). Anxiety and depression among women living with HIV: Prevalence and correlations. Clinical Practice and Epidemiology in Mental Health: CP & EMH, 16(1), 59–66. https://doi.org/10.2174/1745017902016010059
   PubMedGoogle Scholar
• Zunner, B., Dworkin, S. L., Neylan, T. C., Bukusi, E. A., Oyaro, P., Cohen, C. R., Abwok, M., & Meffert, S. M. (2015). HIV, violence and women: Unmet mental health care needs. Journal of Affective Disorders, 174, 619–626. https://doi.org/10.1016/j.jad.2014.12.017
   PubMed Web of Science ®Google Scholar